Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | |
| Sales | 8,364 | 8,381 |
| Cost of Goods | 2,304 | 2,983 |
| Gross Profit | 6,060 | 5,398 |
| Operating Expenses | 5,994 | 5,110 |
| Operating Income | 66 | 288 |
| Other Income | -1,465 | -152 |
| Pre-tax Income | -1,399 | 136 |
| Income Tax | 261 | 62 |
| Net Income Continuous | -1,660 | 74 |
| Net Income | $-1,660 | $74 |
| EPS Basic Total Ops | -0.03 | 0.00 |
| EPS Basic Continuous Ops | -0.03 | N/A |
| EPS Diluted Total Ops | -0.03 | 0.00 |
| EPS Diluted Continuous Ops | -0.03 | N/A |
| EBITDA(a) | $911 | $660 |